Company Listing
Pixium

Pixium has European approval for its bionic vision system, IRIS™, which is able to restore visual perception to blind people. In a clinical study the implant enabled completely blind patients to see light and simple patterns. The technology is suited to patients with degenerative diseases that result in blindness such as retinitis pigmentosa and age-related macular degeneration. The company went public in June 2014.

BACK
Location
Paris, France
CEO
Khalid Ishaque
Abingworth Partner
Tim Haines
Website Address

Home

About Us

  1. About Us
  2. Our Team
  3. Transatlantic Reach
  4. Funds

Strategy

  1. Our Strategy
  2. Venture Capital
  3. Clinical Co‑development
  4. VIPEs
  5. Public Markets

Portfolio

  1. Portfolio Companies
  2. Case Studies

Media Centre

  1. Recent News
  2. Archived News
  3. Film

Contact

  1. Contact Us
  2. Send Us Your Proposal
Company Listing

Pixium has European approval for its bionic vision system, IRIS™, which is able to restore visual perception to blind people. In a clinical study the implant enabled completely blind patients to see light and simple patterns. The technology is suited to patients with degenerative diseases that result in blindness such as retinitis pigmentosa and age-related macular degeneration. The company went public in June 2014.

Location
Paris, France
CEO
Khalid Ishaque
Abingworth Partner
Tim Haines
Website Address
BACK
 
Copyright Abingworth 2017